0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Brucella Abortus Vaccine Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-20L6796
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Brucella Abortus Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Brucella Abortus Vaccine Market Research Report 2025

Code: QYRE-Auto-20L6796
Report
September 2025
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Brucella Abortus Vaccine Market Size

The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years.

Brucella Abortus Vaccine Market

Brucella Abortus Vaccine Market

The global market for Brucella Abortus Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Brucella Abortus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brucella Abortus Vaccine.
The Brucella Abortus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Brucella Abortus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brucella Abortus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Brucella Abortus Vaccine Market Report

Report Metric Details
Report Name Brucella Abortus Vaccine Market
CAGR 5%
Segment by Type
  • DNA Vaccines
  • Subunit Vaccines
  • Vector Vaccines
  • B. Abortus Recombinant Mutants
  • Others
Segment by Application
  • Cattles
  • Sheep
  • Pigs
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis, CEVA, Merck Animal Health, Biovet, CAVAC, JOVAC, Merial, Colorado Serum Company, VECOL, Tecnovax, Indian Immunologicals, Vetal, Dollvet, Centro Diagnostico Veterinario, Onderstepoort Biological Products, Institute of Animal Health and Veterinary Biologicals, Biogenesis Bago, Instituto Rosenbusch, SYVA Laboratorios, CZ Veterinaria, Hester Biosciences, Qilu Animal Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Brucella Abortus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Brucella Abortus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Brucella Abortus Vaccine Market report?

Ans: The main players in the Brucella Abortus Vaccine Market are Zoetis, CEVA, Merck Animal Health, Biovet, CAVAC, JOVAC, Merial, Colorado Serum Company, VECOL, Tecnovax, Indian Immunologicals, Vetal, Dollvet, Centro Diagnostico Veterinario, Onderstepoort Biological Products, Institute of Animal Health and Veterinary Biologicals, Biogenesis Bago, Instituto Rosenbusch, SYVA Laboratorios, CZ Veterinaria, Hester Biosciences, Qilu Animal Health

What are the Application segmentation covered in the Brucella Abortus Vaccine Market report?

Ans: The Applications covered in the Brucella Abortus Vaccine Market report are Cattles, Sheep, Pigs, Others

What are the Type segmentation covered in the Brucella Abortus Vaccine Market report?

Ans: The Types covered in the Brucella Abortus Vaccine Market report are DNA Vaccines, Subunit Vaccines, Vector Vaccines, B. Abortus Recombinant Mutants, Others

1 Brucella Abortus Vaccine Market Overview
1.1 Product Definition
1.2 Brucella Abortus Vaccine by Type
1.2.1 Global Brucella Abortus Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 DNA Vaccines
1.2.3 Subunit Vaccines
1.2.4 Vector Vaccines
1.2.5 B. Abortus Recombinant Mutants
1.2.6 Others
1.3 Brucella Abortus Vaccine by Application
1.3.1 Global Brucella Abortus Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Cattles
1.3.3 Sheep
1.3.4 Pigs
1.3.5 Others
1.4 Global Brucella Abortus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Brucella Abortus Vaccine Revenue 2020-2031
1.4.2 Global Brucella Abortus Vaccine Sales 2020-2031
1.4.3 Global Brucella Abortus Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Brucella Abortus Vaccine Market Competition by Manufacturers
2.1 Global Brucella Abortus Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Brucella Abortus Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Brucella Abortus Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Brucella Abortus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Brucella Abortus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Brucella Abortus Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Brucella Abortus Vaccine, Date of Enter into This Industry
2.8 Global Brucella Abortus Vaccine Market Competitive Situation and Trends
2.8.1 Global Brucella Abortus Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Brucella Abortus Vaccine Players Market Share by Revenue
2.8.3 Global Brucella Abortus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Brucella Abortus Vaccine Market Scenario by Region
3.1 Global Brucella Abortus Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Brucella Abortus Vaccine Sales by Region: 2020-2031
3.2.1 Global Brucella Abortus Vaccine Sales by Region: 2020-2025
3.2.2 Global Brucella Abortus Vaccine Sales by Region: 2026-2031
3.3 Global Brucella Abortus Vaccine Revenue by Region: 2020-2031
3.3.1 Global Brucella Abortus Vaccine Revenue by Region: 2020-2025
3.3.2 Global Brucella Abortus Vaccine Revenue by Region: 2026-2031
3.4 North America Brucella Abortus Vaccine Market Facts & Figures by Country
3.4.1 North America Brucella Abortus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Brucella Abortus Vaccine Sales by Country (2020-2031)
3.4.3 North America Brucella Abortus Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Brucella Abortus Vaccine Market Facts & Figures by Country
3.5.1 Europe Brucella Abortus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Brucella Abortus Vaccine Sales by Country (2020-2031)
3.5.3 Europe Brucella Abortus Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Brucella Abortus Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Brucella Abortus Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Brucella Abortus Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Brucella Abortus Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Brucella Abortus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Brucella Abortus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Brucella Abortus Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Brucella Abortus Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Brucella Abortus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Brucella Abortus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Brucella Abortus Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Brucella Abortus Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Brucella Abortus Vaccine Sales by Type (2020-2031)
4.1.1 Global Brucella Abortus Vaccine Sales by Type (2020-2025)
4.1.2 Global Brucella Abortus Vaccine Sales by Type (2026-2031)
4.1.3 Global Brucella Abortus Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Brucella Abortus Vaccine Revenue by Type (2020-2031)
4.2.1 Global Brucella Abortus Vaccine Revenue by Type (2020-2025)
4.2.2 Global Brucella Abortus Vaccine Revenue by Type (2026-2031)
4.2.3 Global Brucella Abortus Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Brucella Abortus Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Brucella Abortus Vaccine Sales by Application (2020-2031)
5.1.1 Global Brucella Abortus Vaccine Sales by Application (2020-2025)
5.1.2 Global Brucella Abortus Vaccine Sales by Application (2026-2031)
5.1.3 Global Brucella Abortus Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Brucella Abortus Vaccine Revenue by Application (2020-2031)
5.2.1 Global Brucella Abortus Vaccine Revenue by Application (2020-2025)
5.2.2 Global Brucella Abortus Vaccine Revenue by Application (2026-2031)
5.2.3 Global Brucella Abortus Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Brucella Abortus Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zoetis Brucella Abortus Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 CEVA
6.2.1 CEVA Company Information
6.2.2 CEVA Description and Business Overview
6.2.3 CEVA Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CEVA Brucella Abortus Vaccine Product Portfolio
6.2.5 CEVA Recent Developments/Updates
6.3 Merck Animal Health
6.3.1 Merck Animal Health Company Information
6.3.2 Merck Animal Health Description and Business Overview
6.3.3 Merck Animal Health Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Animal Health Brucella Abortus Vaccine Product Portfolio
6.3.5 Merck Animal Health Recent Developments/Updates
6.4 Biovet
6.4.1 Biovet Company Information
6.4.2 Biovet Description and Business Overview
6.4.3 Biovet Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biovet Brucella Abortus Vaccine Product Portfolio
6.4.5 Biovet Recent Developments/Updates
6.5 CAVAC
6.5.1 CAVAC Company Information
6.5.2 CAVAC Description and Business Overview
6.5.3 CAVAC Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CAVAC Brucella Abortus Vaccine Product Portfolio
6.5.5 CAVAC Recent Developments/Updates
6.6 JOVAC
6.6.1 JOVAC Company Information
6.6.2 JOVAC Description and Business Overview
6.6.3 JOVAC Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 JOVAC Brucella Abortus Vaccine Product Portfolio
6.6.5 JOVAC Recent Developments/Updates
6.7 Merial
6.7.1 Merial Company Information
6.7.2 Merial Description and Business Overview
6.7.3 Merial Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merial Brucella Abortus Vaccine Product Portfolio
6.7.5 Merial Recent Developments/Updates
6.8 Colorado Serum Company
6.8.1 Colorado Serum Company Company Information
6.8.2 Colorado Serum Company Description and Business Overview
6.8.3 Colorado Serum Company Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Colorado Serum Company Brucella Abortus Vaccine Product Portfolio
6.8.5 Colorado Serum Company Recent Developments/Updates
6.9 VECOL
6.9.1 VECOL Company Information
6.9.2 VECOL Description and Business Overview
6.9.3 VECOL Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 VECOL Brucella Abortus Vaccine Product Portfolio
6.9.5 VECOL Recent Developments/Updates
6.10 Tecnovax
6.10.1 Tecnovax Company Information
6.10.2 Tecnovax Description and Business Overview
6.10.3 Tecnovax Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Tecnovax Brucella Abortus Vaccine Product Portfolio
6.10.5 Tecnovax Recent Developments/Updates
6.11 Indian Immunologicals
6.11.1 Indian Immunologicals Company Information
6.11.2 Indian Immunologicals Description and Business Overview
6.11.3 Indian Immunologicals Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Indian Immunologicals Brucella Abortus Vaccine Product Portfolio
6.11.5 Indian Immunologicals Recent Developments/Updates
6.12 Vetal
6.12.1 Vetal Company Information
6.12.2 Vetal Description and Business Overview
6.12.3 Vetal Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Vetal Brucella Abortus Vaccine Product Portfolio
6.12.5 Vetal Recent Developments/Updates
6.13 Dollvet
6.13.1 Dollvet Company Information
6.13.2 Dollvet Description and Business Overview
6.13.3 Dollvet Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Dollvet Brucella Abortus Vaccine Product Portfolio
6.13.5 Dollvet Recent Developments/Updates
6.14 Centro Diagnostico Veterinario
6.14.1 Centro Diagnostico Veterinario Company Information
6.14.2 Centro Diagnostico Veterinario Description and Business Overview
6.14.3 Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Portfolio
6.14.5 Centro Diagnostico Veterinario Recent Developments/Updates
6.15 Onderstepoort Biological Products
6.15.1 Onderstepoort Biological Products Company Information
6.15.2 Onderstepoort Biological Products Description and Business Overview
6.15.3 Onderstepoort Biological Products Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Onderstepoort Biological Products Brucella Abortus Vaccine Product Portfolio
6.15.5 Onderstepoort Biological Products Recent Developments/Updates
6.16 Institute of Animal Health and Veterinary Biologicals
6.16.1 Institute of Animal Health and Veterinary Biologicals Company Information
6.16.2 Institute of Animal Health and Veterinary Biologicals Description and Business Overview
6.16.3 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Portfolio
6.16.5 Institute of Animal Health and Veterinary Biologicals Recent Developments/Updates
6.17 Biogenesis Bago
6.17.1 Biogenesis Bago Company Information
6.17.2 Biogenesis Bago Description and Business Overview
6.17.3 Biogenesis Bago Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Biogenesis Bago Brucella Abortus Vaccine Product Portfolio
6.17.5 Biogenesis Bago Recent Developments/Updates
6.18 Instituto Rosenbusch
6.18.1 Instituto Rosenbusch Company Information
6.18.2 Instituto Rosenbusch Description and Business Overview
6.18.3 Instituto Rosenbusch Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Instituto Rosenbusch Brucella Abortus Vaccine Product Portfolio
6.18.5 Instituto Rosenbusch Recent Developments/Updates
6.19 SYVA Laboratorios
6.19.1 SYVA Laboratorios Company Information
6.19.2 SYVA Laboratorios Description and Business Overview
6.19.3 SYVA Laboratorios Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.19.4 SYVA Laboratorios Brucella Abortus Vaccine Product Portfolio
6.19.5 SYVA Laboratorios Recent Developments/Updates
6.20 CZ Veterinaria
6.20.1 CZ Veterinaria Company Information
6.20.2 CZ Veterinaria Description and Business Overview
6.20.3 CZ Veterinaria Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.20.4 CZ Veterinaria Brucella Abortus Vaccine Product Portfolio
6.20.5 CZ Veterinaria Recent Developments/Updates
6.21 Hester Biosciences
6.21.1 Hester Biosciences Company Information
6.21.2 Hester Biosciences Description and Business Overview
6.21.3 Hester Biosciences Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Hester Biosciences Brucella Abortus Vaccine Product Portfolio
6.21.5 Hester Biosciences Recent Developments/Updates
6.22 Qilu Animal Health
6.22.1 Qilu Animal Health Company Information
6.22.2 Qilu Animal Health Description and Business Overview
6.22.3 Qilu Animal Health Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Qilu Animal Health Brucella Abortus Vaccine Product Portfolio
6.22.5 Qilu Animal Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Brucella Abortus Vaccine Industry Chain Analysis
7.2 Brucella Abortus Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Brucella Abortus Vaccine Production Mode & Process Analysis
7.4 Brucella Abortus Vaccine Sales and Marketing
7.4.1 Brucella Abortus Vaccine Sales Channels
7.4.2 Brucella Abortus Vaccine Distributors
7.5 Brucella Abortus Vaccine Customer Analysis
8 Brucella Abortus Vaccine Market Dynamics
8.1 Brucella Abortus Vaccine Industry Trends
8.2 Brucella Abortus Vaccine Market Drivers
8.3 Brucella Abortus Vaccine Market Challenges
8.4 Brucella Abortus Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Brucella Abortus Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Brucella Abortus Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Brucella Abortus Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Brucella Abortus Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Brucella Abortus Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Brucella Abortus Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Brucella Abortus Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Brucella Abortus Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Brucella Abortus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Brucella Abortus Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Brucella Abortus Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Brucella Abortus Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Brucella Abortus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucella Abortus Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Brucella Abortus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Brucella Abortus Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Brucella Abortus Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Brucella Abortus Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Brucella Abortus Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Brucella Abortus Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Brucella Abortus Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Brucella Abortus Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Brucella Abortus Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Brucella Abortus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Brucella Abortus Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Brucella Abortus Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Brucella Abortus Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Brucella Abortus Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Brucella Abortus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Brucella Abortus Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Brucella Abortus Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Brucella Abortus Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Brucella Abortus Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Brucella Abortus Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Brucella Abortus Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Brucella Abortus Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Brucella Abortus Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Brucella Abortus Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Brucella Abortus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Brucella Abortus Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Brucella Abortus Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Brucella Abortus Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Brucella Abortus Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Brucella Abortus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Brucella Abortus Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Brucella Abortus Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Brucella Abortus Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Brucella Abortus Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Brucella Abortus Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Brucella Abortus Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Brucella Abortus Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Brucella Abortus Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Brucella Abortus Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Brucella Abortus Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Brucella Abortus Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Brucella Abortus Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Brucella Abortus Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Brucella Abortus Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Brucella Abortus Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Brucella Abortus Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Brucella Abortus Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Brucella Abortus Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Brucella Abortus Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Brucella Abortus Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Brucella Abortus Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Brucella Abortus Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Brucella Abortus Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Brucella Abortus Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Zoetis Company Information
 Table 71. Zoetis Description and Business Overview
 Table 72. Zoetis Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Zoetis Brucella Abortus Vaccine Product
 Table 74. Zoetis Recent Developments/Updates
 Table 75. CEVA Company Information
 Table 76. CEVA Description and Business Overview
 Table 77. CEVA Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. CEVA Brucella Abortus Vaccine Product
 Table 79. CEVA Recent Developments/Updates
 Table 80. Merck Animal Health Company Information
 Table 81. Merck Animal Health Description and Business Overview
 Table 82. Merck Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Merck Animal Health Brucella Abortus Vaccine Product
 Table 84. Merck Animal Health Recent Developments/Updates
 Table 85. Biovet Company Information
 Table 86. Biovet Description and Business Overview
 Table 87. Biovet Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Biovet Brucella Abortus Vaccine Product
 Table 89. Biovet Recent Developments/Updates
 Table 90. CAVAC Company Information
 Table 91. CAVAC Description and Business Overview
 Table 92. CAVAC Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. CAVAC Brucella Abortus Vaccine Product
 Table 94. CAVAC Recent Developments/Updates
 Table 95. JOVAC Company Information
 Table 96. JOVAC Description and Business Overview
 Table 97. JOVAC Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. JOVAC Brucella Abortus Vaccine Product
 Table 99. JOVAC Recent Developments/Updates
 Table 100. Merial Company Information
 Table 101. Merial Description and Business Overview
 Table 102. Merial Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Merial Brucella Abortus Vaccine Product
 Table 104. Merial Recent Developments/Updates
 Table 105. Colorado Serum Company Company Information
 Table 106. Colorado Serum Company Description and Business Overview
 Table 107. Colorado Serum Company Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Colorado Serum Company Brucella Abortus Vaccine Product
 Table 109. Colorado Serum Company Recent Developments/Updates
 Table 110. VECOL Company Information
 Table 111. VECOL Description and Business Overview
 Table 112. VECOL Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. VECOL Brucella Abortus Vaccine Product
 Table 114. VECOL Recent Developments/Updates
 Table 115. Tecnovax Company Information
 Table 116. Tecnovax Description and Business Overview
 Table 117. Tecnovax Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Tecnovax Brucella Abortus Vaccine Product
 Table 119. Tecnovax Recent Developments/Updates
 Table 120. Indian Immunologicals Company Information
 Table 121. Indian Immunologicals Description and Business Overview
 Table 122. Indian Immunologicals Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Indian Immunologicals Brucella Abortus Vaccine Product
 Table 124. Indian Immunologicals Recent Developments/Updates
 Table 125. Vetal Company Information
 Table 126. Vetal Description and Business Overview
 Table 127. Vetal Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Vetal Brucella Abortus Vaccine Product
 Table 129. Vetal Recent Developments/Updates
 Table 130. Dollvet Company Information
 Table 131. Dollvet Description and Business Overview
 Table 132. Dollvet Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Dollvet Brucella Abortus Vaccine Product
 Table 134. Dollvet Recent Developments/Updates
 Table 135. Centro Diagnostico Veterinario Company Information
 Table 136. Centro Diagnostico Veterinario Description and Business Overview
 Table 137. Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Centro Diagnostico Veterinario Brucella Abortus Vaccine Product
 Table 139. Centro Diagnostico Veterinario Recent Developments/Updates
 Table 140. Onderstepoort Biological Products Company Information
 Table 141. Onderstepoort Biological Products Description and Business Overview
 Table 142. Onderstepoort Biological Products Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Onderstepoort Biological Products Brucella Abortus Vaccine Product
 Table 144. Onderstepoort Biological Products Recent Developments/Updates
 Table 145. Institute of Animal Health and Veterinary Biologicals Company Information
 Table 146. Institute of Animal Health and Veterinary Biologicals Description and Business Overview
 Table 147. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product
 Table 149. Institute of Animal Health and Veterinary Biologicals Recent Developments/Updates
 Table 150. Biogenesis Bago Company Information
 Table 151. Biogenesis Bago Description and Business Overview
 Table 152. Biogenesis Bago Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Biogenesis Bago Brucella Abortus Vaccine Product
 Table 154. Biogenesis Bago Recent Developments/Updates
 Table 155. Instituto Rosenbusch Company Information
 Table 156. Instituto Rosenbusch Description and Business Overview
 Table 157. Instituto Rosenbusch Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Instituto Rosenbusch Brucella Abortus Vaccine Product
 Table 159. Instituto Rosenbusch Recent Developments/Updates
 Table 160. SYVA Laboratorios Company Information
 Table 161. SYVA Laboratorios Description and Business Overview
 Table 162. SYVA Laboratorios Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. SYVA Laboratorios Brucella Abortus Vaccine Product
 Table 164. SYVA Laboratorios Recent Developments/Updates
 Table 165. CZ Veterinaria Company Information
 Table 166. CZ Veterinaria Description and Business Overview
 Table 167. CZ Veterinaria Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. CZ Veterinaria Brucella Abortus Vaccine Product
 Table 169. CZ Veterinaria Recent Developments/Updates
 Table 170. Hester Biosciences Company Information
 Table 171. Hester Biosciences Description and Business Overview
 Table 172. Hester Biosciences Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Hester Biosciences Brucella Abortus Vaccine Product
 Table 174. Hester Biosciences Recent Developments/Updates
 Table 175. Qilu Animal Health Company Information
 Table 176. Qilu Animal Health Description and Business Overview
 Table 177. Qilu Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Qilu Animal Health Brucella Abortus Vaccine Product
 Table 179. Qilu Animal Health Recent Developments/Updates
 Table 180. Key Raw Materials Lists
 Table 181. Raw Materials Key Suppliers Lists
 Table 182. Brucella Abortus Vaccine Distributors List
 Table 183. Brucella Abortus Vaccine Customers List
 Table 184. Brucella Abortus Vaccine Market Trends
 Table 185. Brucella Abortus Vaccine Market Drivers
 Table 186. Brucella Abortus Vaccine Market Challenges
 Table 187. Brucella Abortus Vaccine Market Restraints
 Table 188. Research Programs/Design for This Report
 Table 189. Key Data Information from Secondary Sources
 Table 190. Key Data Information from Primary Sources
 Table 191. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Brucella Abortus Vaccine
 Figure 2. Global Brucella Abortus Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Brucella Abortus Vaccine Market Share by Type: 2024 & 2031
 Figure 4. DNA Vaccines Product Picture
 Figure 5. Subunit Vaccines Product Picture
 Figure 6. Vector Vaccines Product Picture
 Figure 7. B. Abortus Recombinant Mutants Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Brucella Abortus Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Brucella Abortus Vaccine Market Share by Application: 2024 & 2031
 Figure 11. Cattles
 Figure 12. Sheep
 Figure 13. Pigs
 Figure 14. Others
 Figure 15. Global Brucella Abortus Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Brucella Abortus Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Brucella Abortus Vaccine Sales (2020-2031) & (K Units)
 Figure 18. Global Brucella Abortus Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 19. Brucella Abortus Vaccine Report Years Considered
 Figure 20. Brucella Abortus Vaccine Sales Share by Manufacturers in 2024
 Figure 21. Global Brucella Abortus Vaccine Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Brucella Abortus Vaccine Players: Market Share by Revenue in Brucella Abortus Vaccine in 2024
 Figure 23. Brucella Abortus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Brucella Abortus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Brucella Abortus Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. North America Brucella Abortus Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Brucella Abortus Vaccine Sales Market Share by Country (2020-2031)
 Figure 30. Europe Brucella Abortus Vaccine Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Brucella Abortus Vaccine Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Brucella Abortus Vaccine Revenue Market Share by Region (2020-2031)
 Figure 38. China Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Brucella Abortus Vaccine Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Brucella Abortus Vaccine Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Brucella Abortus Vaccine Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Brucella Abortus Vaccine Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE Brucella Abortus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Brucella Abortus Vaccine by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Brucella Abortus Vaccine by Type (2020-2031)
 Figure 60. Global Brucella Abortus Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Brucella Abortus Vaccine by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Brucella Abortus Vaccine by Application (2020-2031)
 Figure 63. Global Brucella Abortus Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 64. Brucella Abortus Vaccine Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS